Insider Transactions in Q1 2024 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,573
-0.31%
|
$3,573
$1.3 P/Share
|
|
Mar 01
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,155
-1.83%
|
$6,155
$1.2 P/Share
|
|
Mar 01
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,969
-1.68%
|
$5,969
$1.2 P/Share
|
|
Mar 01
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
19,374
-1.64%
|
$19,374
$1.2 P/Share
|
|
Mar 01
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,109
-1.28%
|
$5,109
$1.2 P/Share
|
|
Mar 01
2024
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
3,576
-1.27%
|
$3,576
$1.2 P/Share
|
|
Mar 01
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
6,162
-1.52%
|
$6,162
$1.2 P/Share
|
|
Feb 29
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
16,311
-4.63%
|
$16,311
$1.17 P/Share
|
|
Feb 29
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,667
-4.22%
|
$15,667
$1.17 P/Share
|
|
Feb 29
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
80,470
-6.37%
|
$80,470
$1.17 P/Share
|
|
Feb 29
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
21,840
-5.19%
|
$21,840
$1.17 P/Share
|
|
Feb 29
2024
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
16,973
-5.69%
|
$16,973
$1.17 P/Share
|
|
Feb 29
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
27,687
-6.4%
|
$27,687
$1.17 P/Share
|
|
Feb 28
2024
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
442,800
+25.94%
|
-
|
|
Feb 28
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,959
+32.12%
|
-
|
|
Feb 28
2024
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
147,000
+33.0%
|
-
|
|
Feb 28
2024
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
188,205
+30.32%
|
-
|
|
Feb 28
2024
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
188,205
+34.84%
|
-
|
|
Feb 28
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,959
+34.89%
|
-
|
|
Feb 27
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,545
-1.03%
|
$2,545
$1.32 P/Share
|
|
Feb 15
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,847
-1.72%
|
$5,847
$1.37 P/Share
|
|
Feb 06
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
4,205
-1.67%
|
$4,205
$1.59 P/Share
|
|
Feb 06
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
4,012
-0.49%
|
$4,012
$1.59 P/Share
|
|
Jan 24
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,167
+6.01%
|
-
|
|
Jan 24
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,167
+7.59%
|
-
|
|
Jan 24
2024
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+7.29%
|
-
|
|
Jan 24
2024
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,167
+5.71%
|
-
|
|
Jan 24
2024
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+5.04%
|
-
|
|
Jan 24
2024
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+4.84%
|
-
|
|
Jan 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
4,114
-0.52%
|
$0
$0.82 P/Share
|